nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—migraine—Prednisone—atopic dermatitis	0.752	1	CpDpCtD
Naratriptan—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000131	0.000609	CcSEcCtD
Naratriptan—Pruritus—Tacrolimus—atopic dermatitis	0.000131	0.000607	CcSEcCtD
Naratriptan—Malaise—Prednisolone—atopic dermatitis	0.000131	0.000606	CcSEcCtD
Naratriptan—Vertigo—Prednisolone—atopic dermatitis	0.00013	0.000603	CcSEcCtD
Naratriptan—Syncope—Prednisolone—atopic dermatitis	0.00013	0.000602	CcSEcCtD
Naratriptan—Malaise—Hydrocortisone—atopic dermatitis	0.000128	0.000591	CcSEcCtD
Naratriptan—Loss of consciousness—Prednisolone—atopic dermatitis	0.000127	0.00059	CcSEcCtD
Naratriptan—Vertigo—Hydrocortisone—atopic dermatitis	0.000127	0.000589	CcSEcCtD
Naratriptan—Syncope—Hydrocortisone—atopic dermatitis	0.000127	0.000588	CcSEcCtD
Naratriptan—Diarrhoea—Tacrolimus—atopic dermatitis	0.000127	0.000587	CcSEcCtD
Naratriptan—Angiopathy—Betamethasone—atopic dermatitis	0.000126	0.000584	CcSEcCtD
Naratriptan—Angiopathy—Dexamethasone—atopic dermatitis	0.000126	0.000584	CcSEcCtD
Naratriptan—Convulsion—Prednisolone—atopic dermatitis	0.000125	0.000582	CcSEcCtD
Naratriptan—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000124	0.000576	CcSEcCtD
Naratriptan—Arrhythmia—Dexamethasone—atopic dermatitis	0.000124	0.000575	CcSEcCtD
Naratriptan—Arrhythmia—Betamethasone—atopic dermatitis	0.000124	0.000575	CcSEcCtD
Naratriptan—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000124	0.000573	CcSEcCtD
Naratriptan—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000123	0.000572	CcSEcCtD
Naratriptan—Bradycardia—Prednisone—atopic dermatitis	0.000123	0.000571	CcSEcCtD
Naratriptan—Alopecia—Betamethasone—atopic dermatitis	0.000123	0.000569	CcSEcCtD
Naratriptan—Alopecia—Dexamethasone—atopic dermatitis	0.000123	0.000569	CcSEcCtD
Naratriptan—Convulsion—Hydrocortisone—atopic dermatitis	0.000123	0.000568	CcSEcCtD
Naratriptan—Dizziness—Tacrolimus—atopic dermatitis	0.000122	0.000567	CcSEcCtD
Naratriptan—Discomfort—Prednisolone—atopic dermatitis	0.000122	0.000565	CcSEcCtD
Naratriptan—Haemoglobin—Prednisone—atopic dermatitis	0.000122	0.000563	CcSEcCtD
Naratriptan—Haemorrhage—Prednisone—atopic dermatitis	0.000121	0.000561	CcSEcCtD
Naratriptan—Erythema—Betamethasone—atopic dermatitis	0.000121	0.00056	CcSEcCtD
Naratriptan—Erythema—Dexamethasone—atopic dermatitis	0.000121	0.00056	CcSEcCtD
Naratriptan—Myalgia—Hydrocortisone—atopic dermatitis	0.00012	0.000558	CcSEcCtD
Naratriptan—Hallucination—Prednisone—atopic dermatitis	0.00012	0.000558	CcSEcCtD
Naratriptan—Malaise—Triamcinolone—atopic dermatitis	0.00012	0.000557	CcSEcCtD
Naratriptan—Anxiety—Hydrocortisone—atopic dermatitis	0.00012	0.000556	CcSEcCtD
Naratriptan—Malaise—Methylprednisolone—atopic dermatitis	0.00012	0.000556	CcSEcCtD
Naratriptan—Vertigo—Triamcinolone—atopic dermatitis	0.00012	0.000555	CcSEcCtD
Naratriptan—Syncope—Triamcinolone—atopic dermatitis	0.000119	0.000554	CcSEcCtD
Naratriptan—Vertigo—Methylprednisolone—atopic dermatitis	0.000119	0.000554	CcSEcCtD
Naratriptan—Syncope—Methylprednisolone—atopic dermatitis	0.000119	0.000553	CcSEcCtD
Naratriptan—Discomfort—Hydrocortisone—atopic dermatitis	0.000119	0.000552	CcSEcCtD
Naratriptan—Oedema—Prednisolone—atopic dermatitis	0.000118	0.000548	CcSEcCtD
Naratriptan—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000118	0.000548	CcSEcCtD
Naratriptan—Vomiting—Tacrolimus—atopic dermatitis	0.000118	0.000546	CcSEcCtD
Naratriptan—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000117	0.000543	CcSEcCtD
Naratriptan—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000117	0.000542	CcSEcCtD
Naratriptan—Rash—Tacrolimus—atopic dermatitis	0.000117	0.000541	CcSEcCtD
Naratriptan—Dermatitis—Tacrolimus—atopic dermatitis	0.000117	0.000541	CcSEcCtD
Naratriptan—Shock—Prednisolone—atopic dermatitis	0.000116	0.000539	CcSEcCtD
Naratriptan—Cough—Triamcinolone—atopic dermatitis	0.000116	0.000539	CcSEcCtD
Naratriptan—Headache—Tacrolimus—atopic dermatitis	0.000116	0.000538	CcSEcCtD
Naratriptan—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000115	0.000535	CcSEcCtD
Naratriptan—Oedema—Hydrocortisone—atopic dermatitis	0.000115	0.000535	CcSEcCtD
Naratriptan—Convulsion—Triamcinolone—atopic dermatitis	0.000115	0.000535	CcSEcCtD
Naratriptan—Convulsion—Methylprednisolone—atopic dermatitis	0.000115	0.000534	CcSEcCtD
Naratriptan—Infection—Hydrocortisone—atopic dermatitis	0.000115	0.000532	CcSEcCtD
Naratriptan—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000114	0.00053	CcSEcCtD
Naratriptan—Shock—Hydrocortisone—atopic dermatitis	0.000114	0.000527	CcSEcCtD
Naratriptan—Myalgia—Triamcinolone—atopic dermatitis	0.000113	0.000526	CcSEcCtD
Naratriptan—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000113	0.000525	CcSEcCtD
Naratriptan—Myalgia—Methylprednisolone—atopic dermatitis	0.000113	0.000525	CcSEcCtD
Naratriptan—Arthralgia—Methylprednisolone—atopic dermatitis	0.000113	0.000525	CcSEcCtD
Naratriptan—Anxiety—Methylprednisolone—atopic dermatitis	0.000113	0.000523	CcSEcCtD
Naratriptan—Skin disorder—Hydrocortisone—atopic dermatitis	0.000112	0.00052	CcSEcCtD
Naratriptan—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000112	0.00052	CcSEcCtD
Naratriptan—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000112	0.00052	CcSEcCtD
Naratriptan—Discomfort—Triamcinolone—atopic dermatitis	0.000112	0.000519	CcSEcCtD
Naratriptan—Discomfort—Methylprednisolone—atopic dermatitis	0.000112	0.000518	CcSEcCtD
Naratriptan—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000112	0.000517	CcSEcCtD
Naratriptan—Dry mouth—Triamcinolone—atopic dermatitis	0.000111	0.000514	CcSEcCtD
Naratriptan—Nausea—Tacrolimus—atopic dermatitis	0.00011	0.00051	CcSEcCtD
Naratriptan—Angiopathy—Prednisone—atopic dermatitis	0.00011	0.000509	CcSEcCtD
Naratriptan—Confusional state—Methylprednisolone—atopic dermatitis	0.000109	0.000507	CcSEcCtD
Naratriptan—Immune system disorder—Prednisone—atopic dermatitis	0.000109	0.000506	CcSEcCtD
Naratriptan—Malaise—Dexamethasone—atopic dermatitis	0.000109	0.000505	CcSEcCtD
Naratriptan—Malaise—Betamethasone—atopic dermatitis	0.000109	0.000505	CcSEcCtD
Naratriptan—Oedema—Triamcinolone—atopic dermatitis	0.000109	0.000504	CcSEcCtD
Naratriptan—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000109	0.000504	CcSEcCtD
Naratriptan—Vertigo—Dexamethasone—atopic dermatitis	0.000109	0.000503	CcSEcCtD
Naratriptan—Vertigo—Betamethasone—atopic dermatitis	0.000109	0.000503	CcSEcCtD
Naratriptan—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000108	0.000503	CcSEcCtD
Naratriptan—Syncope—Dexamethasone—atopic dermatitis	0.000108	0.000503	CcSEcCtD
Naratriptan—Syncope—Betamethasone—atopic dermatitis	0.000108	0.000503	CcSEcCtD
Naratriptan—Arrhythmia—Prednisone—atopic dermatitis	0.000108	0.000501	CcSEcCtD
Naratriptan—Infection—Triamcinolone—atopic dermatitis	0.000108	0.000501	CcSEcCtD
Naratriptan—Hypotension—Hydrocortisone—atopic dermatitis	0.000108	0.0005	CcSEcCtD
Naratriptan—Infection—Methylprednisolone—atopic dermatitis	0.000108	0.0005	CcSEcCtD
Naratriptan—HTR1D—GPCR downstream signaling—CCL27—atopic dermatitis	0.000107	0.00334	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL22—atopic dermatitis	0.000107	0.00333	CbGpPWpGaD
Naratriptan—Shock—Triamcinolone—atopic dermatitis	0.000107	0.000496	CcSEcCtD
Naratriptan—Alopecia—Prednisone—atopic dermatitis	0.000107	0.000495	CcSEcCtD
Naratriptan—Shock—Methylprednisolone—atopic dermatitis	0.000107	0.000495	CcSEcCtD
Naratriptan—HTR1F—GPCR ligand binding—CCL5—atopic dermatitis	0.000107	0.00331	CbGpPWpGaD
Naratriptan—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000106	0.000493	CcSEcCtD
Naratriptan—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000106	0.000493	CcSEcCtD
Naratriptan—Loss of consciousness—Betamethasone—atopic dermatitis	0.000106	0.000493	CcSEcCtD
Naratriptan—Paraesthesia—Prednisolone—atopic dermatitis	0.000106	0.000492	CcSEcCtD
Naratriptan—Skin disorder—Methylprednisolone—atopic dermatitis	0.000105	0.000488	CcSEcCtD
Naratriptan—Erythema—Prednisone—atopic dermatitis	0.000105	0.000488	CcSEcCtD
Naratriptan—HTR1B—GPCR downstream signaling—CCL27—atopic dermatitis	0.000105	0.00327	CbGpPWpGaD
Naratriptan—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000105	0.000488	CcSEcCtD
Naratriptan—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000105	0.000487	CcSEcCtD
Naratriptan—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000105	0.000486	CcSEcCtD
Naratriptan—Convulsion—Dexamethasone—atopic dermatitis	0.000105	0.000486	CcSEcCtD
Naratriptan—Convulsion—Betamethasone—atopic dermatitis	0.000105	0.000486	CcSEcCtD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000104	0.00323	CbGpPWpGaD
Naratriptan—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000104	0.000481	CcSEcCtD
Naratriptan—Myalgia—Dexamethasone—atopic dermatitis	0.000103	0.000477	CcSEcCtD
Naratriptan—Myalgia—Betamethasone—atopic dermatitis	0.000103	0.000477	CcSEcCtD
Naratriptan—HTR1A—GPCR ligand binding—CCL11—atopic dermatitis	0.000103	0.00318	CbGpPWpGaD
Naratriptan—Anxiety—Betamethasone—atopic dermatitis	0.000103	0.000475	CcSEcCtD
Naratriptan—Anxiety—Dexamethasone—atopic dermatitis	0.000103	0.000475	CcSEcCtD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000102	0.00316	CbGpPWpGaD
Naratriptan—Discomfort—Betamethasone—atopic dermatitis	0.000102	0.000471	CcSEcCtD
Naratriptan—Discomfort—Dexamethasone—atopic dermatitis	0.000102	0.000471	CcSEcCtD
Naratriptan—HTR1D—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000101	0.00315	CbGpPWpGaD
Naratriptan—Hypotension—Methylprednisolone—atopic dermatitis	0.000101	0.00047	CcSEcCtD
Naratriptan—HTR1F—Signaling Pathways—CCL22—atopic dermatitis	0.000101	0.00314	CbGpPWpGaD
Naratriptan—Pain—Prednisolone—atopic dermatitis	0.000101	0.000469	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—NPS—atopic dermatitis	9.99e-05	0.0031	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—TAC1—atopic dermatitis	9.99e-05	0.0031	CbGpPWpGaD
Naratriptan—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	9.97e-05	0.000462	CcSEcCtD
Naratriptan—Fatigue—Hydrocortisone—atopic dermatitis	9.95e-05	0.000461	CcSEcCtD
Naratriptan—HTR1B—G alpha (i) signalling events—CCR5—atopic dermatitis	9.93e-05	0.00308	CbGpPWpGaD
Naratriptan—Vision blurred—Prednisone—atopic dermatitis	9.92e-05	0.00046	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—CCR3—atopic dermatitis	9.9e-05	0.00307	CbGpPWpGaD
Naratriptan—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	9.9e-05	0.000459	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	9.88e-05	0.000458	CcSEcCtD
Naratriptan—Pain—Hydrocortisone—atopic dermatitis	9.87e-05	0.000458	CcSEcCtD
Naratriptan—Anaphylactic shock—Betamethasone—atopic dermatitis	9.86e-05	0.000457	CcSEcCtD
Naratriptan—Oedema—Dexamethasone—atopic dermatitis	9.86e-05	0.000457	CcSEcCtD
Naratriptan—Oedema—Betamethasone—atopic dermatitis	9.86e-05	0.000457	CcSEcCtD
Naratriptan—Anaphylactic shock—Dexamethasone—atopic dermatitis	9.86e-05	0.000457	CcSEcCtD
Naratriptan—Infection—Dexamethasone—atopic dermatitis	9.8e-05	0.000454	CcSEcCtD
Naratriptan—Infection—Betamethasone—atopic dermatitis	9.8e-05	0.000454	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—CXCR3—atopic dermatitis	9.8e-05	0.00304	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	9.79e-05	0.00304	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	9.79e-05	0.00304	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—TAC1—atopic dermatitis	9.78e-05	0.00304	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—NPS—atopic dermatitis	9.78e-05	0.00304	CbGpPWpGaD
Naratriptan—Ill-defined disorder—Prednisone—atopic dermatitis	9.76e-05	0.000453	CcSEcCtD
Naratriptan—Paraesthesia—Triamcinolone—atopic dermatitis	9.76e-05	0.000453	CcSEcCtD
Naratriptan—HTR1D—Signaling by GPCR—CCL27—atopic dermatitis	9.76e-05	0.00303	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—CXCL10—atopic dermatitis	9.76e-05	0.00303	CbGpPWpGaD
Naratriptan—Feeling abnormal—Prednisolone—atopic dermatitis	9.74e-05	0.000452	CcSEcCtD
Naratriptan—Paraesthesia—Methylprednisolone—atopic dermatitis	9.74e-05	0.000452	CcSEcCtD
Naratriptan—Anaemia—Prednisone—atopic dermatitis	9.73e-05	0.000451	CcSEcCtD
Naratriptan—Shock—Betamethasone—atopic dermatitis	9.7e-05	0.00045	CcSEcCtD
Naratriptan—Shock—Dexamethasone—atopic dermatitis	9.7e-05	0.00045	CcSEcCtD
Naratriptan—Dyspnoea—Triamcinolone—atopic dermatitis	9.69e-05	0.000449	CcSEcCtD
Naratriptan—Nervous system disorder—Dexamethasone—atopic dermatitis	9.67e-05	0.000448	CcSEcCtD
Naratriptan—Nervous system disorder—Betamethasone—atopic dermatitis	9.67e-05	0.000448	CcSEcCtD
Naratriptan—Agitation—Prednisone—atopic dermatitis	9.67e-05	0.000448	CcSEcCtD
Naratriptan—Thrombocytopenia—Dexamethasone—atopic dermatitis	9.66e-05	0.000448	CcSEcCtD
Naratriptan—Thrombocytopenia—Betamethasone—atopic dermatitis	9.66e-05	0.000448	CcSEcCtD
Naratriptan—HTR1F—GPCR ligand binding—CCR5—atopic dermatitis	9.6e-05	0.00298	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	9.6e-05	0.00298	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CXCR3—atopic dermatitis	9.59e-05	0.00298	CbGpPWpGaD
Naratriptan—HTR1F—G alpha (i) signalling events—CXCL8—atopic dermatitis	9.59e-05	0.00298	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL27—atopic dermatitis	9.56e-05	0.00297	CbGpPWpGaD
Naratriptan—Hyperhidrosis—Betamethasone—atopic dermatitis	9.53e-05	0.000442	CcSEcCtD
Naratriptan—Hyperhidrosis—Dexamethasone—atopic dermatitis	9.53e-05	0.000442	CcSEcCtD
Naratriptan—Feeling abnormal—Hydrocortisone—atopic dermatitis	9.51e-05	0.000441	CcSEcCtD
Naratriptan—Malaise—Prednisone—atopic dermatitis	9.49e-05	0.00044	CcSEcCtD
Naratriptan—Vertigo—Prednisone—atopic dermatitis	9.46e-05	0.000438	CcSEcCtD
Naratriptan—Syncope—Prednisone—atopic dermatitis	9.44e-05	0.000438	CcSEcCtD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	9.41e-05	0.00292	CbGpPWpGaD
Naratriptan—Urticaria—Prednisolone—atopic dermatitis	9.39e-05	0.000435	CcSEcCtD
Naratriptan—Fatigue—Triamcinolone—atopic dermatitis	9.37e-05	0.000435	CcSEcCtD
Naratriptan—Fatigue—Methylprednisolone—atopic dermatitis	9.35e-05	0.000434	CcSEcCtD
Naratriptan—Pain—Triamcinolone—atopic dermatitis	9.3e-05	0.000431	CcSEcCtD
Naratriptan—Loss of consciousness—Prednisone—atopic dermatitis	9.25e-05	0.000429	CcSEcCtD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	9.22e-05	0.00286	CbGpPWpGaD
Naratriptan—Hypotension—Dexamethasone—atopic dermatitis	9.22e-05	0.000427	CcSEcCtD
Naratriptan—Hypotension—Betamethasone—atopic dermatitis	9.22e-05	0.000427	CcSEcCtD
Naratriptan—Urticaria—Hydrocortisone—atopic dermatitis	9.17e-05	0.000425	CcSEcCtD
Naratriptan—Body temperature increased—Hydrocortisone—atopic dermatitis	9.13e-05	0.000423	CcSEcCtD
Naratriptan—Convulsion—Prednisone—atopic dermatitis	9.12e-05	0.000423	CcSEcCtD
Naratriptan—HTR1F—Signaling Pathways—CCL27—atopic dermatitis	9.02e-05	0.0028	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CCR3—atopic dermatitis	8.99e-05	0.00279	CbGpPWpGaD
Naratriptan—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	8.99e-05	0.000417	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	8.99e-05	0.000417	CcSEcCtD
Naratriptan—Arthralgia—Prednisone—atopic dermatitis	8.96e-05	0.000415	CcSEcCtD
Naratriptan—Myalgia—Prednisone—atopic dermatitis	8.96e-05	0.000415	CcSEcCtD
Naratriptan—Feeling abnormal—Triamcinolone—atopic dermatitis	8.96e-05	0.000415	CcSEcCtD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	8.95e-05	0.00278	CbGpPWpGaD
Naratriptan—Feeling abnormal—Methylprednisolone—atopic dermatitis	8.94e-05	0.000414	CcSEcCtD
Naratriptan—Anxiety—Prednisone—atopic dermatitis	8.93e-05	0.000414	CcSEcCtD
Naratriptan—Paraesthesia—Betamethasone—atopic dermatitis	8.86e-05	0.000411	CcSEcCtD
Naratriptan—Paraesthesia—Dexamethasone—atopic dermatitis	8.86e-05	0.000411	CcSEcCtD
Naratriptan—Discomfort—Prednisone—atopic dermatitis	8.85e-05	0.00041	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—TAC1—atopic dermatitis	8.83e-05	0.00274	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—NPS—atopic dermatitis	8.83e-05	0.00274	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	8.77e-05	0.00272	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCL17—atopic dermatitis	8.75e-05	0.00272	CbGpPWpGaD
Naratriptan—Hypersensitivity—Prednisolone—atopic dermatitis	8.71e-05	0.000404	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—CXCR3—atopic dermatitis	8.66e-05	0.00269	CbGpPWpGaD
Naratriptan—Urticaria—Triamcinolone—atopic dermatitis	8.64e-05	0.0004	CcSEcCtD
Naratriptan—Urticaria—Methylprednisolone—atopic dermatitis	8.62e-05	0.0004	CcSEcCtD
Naratriptan—Body temperature increased—Triamcinolone—atopic dermatitis	8.59e-05	0.000398	CcSEcCtD
Naratriptan—Oedema—Prednisone—atopic dermatitis	8.59e-05	0.000398	CcSEcCtD
Naratriptan—Anaphylactic shock—Prednisone—atopic dermatitis	8.59e-05	0.000398	CcSEcCtD
Naratriptan—HTR1B—Signaling by GPCR—CCL17—atopic dermatitis	8.57e-05	0.00266	CbGpPWpGaD
Naratriptan—Infection—Prednisone—atopic dermatitis	8.53e-05	0.000396	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Betamethasone—atopic dermatitis	8.51e-05	0.000395	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	8.51e-05	0.000395	CcSEcCtD
Naratriptan—Hypersensitivity—Hydrocortisone—atopic dermatitis	8.51e-05	0.000394	CcSEcCtD
Naratriptan—Fatigue—Dexamethasone—atopic dermatitis	8.5e-05	0.000394	CcSEcCtD
Naratriptan—Fatigue—Betamethasone—atopic dermatitis	8.5e-05	0.000394	CcSEcCtD
Naratriptan—Shock—Prednisone—atopic dermatitis	8.45e-05	0.000392	CcSEcCtD
Naratriptan—Pain—Betamethasone—atopic dermatitis	8.43e-05	0.000391	CcSEcCtD
Naratriptan—Pain—Dexamethasone—atopic dermatitis	8.43e-05	0.000391	CcSEcCtD
Naratriptan—Nervous system disorder—Prednisone—atopic dermatitis	8.42e-05	0.000391	CcSEcCtD
Naratriptan—HTR1A—G alpha (i) signalling events—CCL5—atopic dermatitis	8.4e-05	0.00261	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CCR3—atopic dermatitis	8.36e-05	0.0026	CbGpPWpGaD
Naratriptan—Skin disorder—Prednisone—atopic dermatitis	8.34e-05	0.000387	CcSEcCtD
Naratriptan—Hyperhidrosis—Prednisone—atopic dermatitis	8.3e-05	0.000385	CcSEcCtD
Naratriptan—Asthenia—Hydrocortisone—atopic dermatitis	8.28e-05	0.000384	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—IL5—atopic dermatitis	8.21e-05	0.00255	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL22—atopic dermatitis	8.17e-05	0.00254	CbGpPWpGaD
Naratriptan—Pruritus—Hydrocortisone—atopic dermatitis	8.17e-05	0.000379	CcSEcCtD
Naratriptan—Feeling abnormal—Dexamethasone—atopic dermatitis	8.13e-05	0.000377	CcSEcCtD
Naratriptan—Feeling abnormal—Betamethasone—atopic dermatitis	8.13e-05	0.000377	CcSEcCtD
Naratriptan—HTR1F—Signaling Pathways—CCL17—atopic dermatitis	8.09e-05	0.00251	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	8.06e-05	0.0025	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—TAC1—atopic dermatitis	8.02e-05	0.00249	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—NPS—atopic dermatitis	8.02e-05	0.00249	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCL27—atopic dermatitis	8.02e-05	0.00249	CbGpPWpGaD
Naratriptan—Hypersensitivity—Triamcinolone—atopic dermatitis	8.01e-05	0.000371	CcSEcCtD
Naratriptan—Hypersensitivity—Methylprednisolone—atopic dermatitis	7.99e-05	0.000371	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—CXCL10—atopic dermatitis	7.92e-05	0.00246	CbGpPWpGaD
Naratriptan—Diarrhoea—Hydrocortisone—atopic dermatitis	7.9e-05	0.000366	CcSEcCtD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	7.9e-05	0.00245	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CXCR3—atopic dermatitis	7.86e-05	0.00244	CbGpPWpGaD
Naratriptan—Urticaria—Dexamethasone—atopic dermatitis	7.84e-05	0.000363	CcSEcCtD
Naratriptan—Urticaria—Betamethasone—atopic dermatitis	7.84e-05	0.000363	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Prednisone—atopic dermatitis	7.83e-05	0.000363	CcSEcCtD
Naratriptan—Dizziness—Prednisolone—atopic dermatitis	7.82e-05	0.000362	CcSEcCtD
Naratriptan—Asthenia—Triamcinolone—atopic dermatitis	7.8e-05	0.000362	CcSEcCtD
Naratriptan—Body temperature increased—Dexamethasone—atopic dermatitis	7.8e-05	0.000362	CcSEcCtD
Naratriptan—Body temperature increased—Betamethasone—atopic dermatitis	7.8e-05	0.000362	CcSEcCtD
Naratriptan—Asthenia—Methylprednisolone—atopic dermatitis	7.78e-05	0.000361	CcSEcCtD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	7.76e-05	0.00241	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CXCL10—atopic dermatitis	7.75e-05	0.00241	CbGpPWpGaD
Naratriptan—Paraesthesia—Prednisone—atopic dermatitis	7.71e-05	0.000358	CcSEcCtD
Naratriptan—Pruritus—Triamcinolone—atopic dermatitis	7.69e-05	0.000357	CcSEcCtD
Naratriptan—Pruritus—Methylprednisolone—atopic dermatitis	7.67e-05	0.000356	CcSEcCtD
Naratriptan—Dizziness—Hydrocortisone—atopic dermatitis	7.63e-05	0.000354	CcSEcCtD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.62e-05	0.00237	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—CCR5—atopic dermatitis	7.57e-05	0.00235	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	7.47e-05	0.00232	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL5—atopic dermatitis	7.45e-05	0.00231	CbGpPWpGaD
Naratriptan—Rash—Prednisolone—atopic dermatitis	7.45e-05	0.000346	CcSEcCtD
Naratriptan—HTR1A—GPCR ligand binding—NPS—atopic dermatitis	7.45e-05	0.00231	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—TAC1—atopic dermatitis	7.45e-05	0.00231	CbGpPWpGaD
Naratriptan—Dermatitis—Prednisolone—atopic dermatitis	7.45e-05	0.000345	CcSEcCtD
Naratriptan—Diarrhoea—Methylprednisolone—atopic dermatitis	7.42e-05	0.000344	CcSEcCtD
Naratriptan—Fatigue—Prednisone—atopic dermatitis	7.41e-05	0.000343	CcSEcCtD
Naratriptan—Headache—Prednisolone—atopic dermatitis	7.4e-05	0.000343	CcSEcCtD
Naratriptan—Constipation—Prednisone—atopic dermatitis	7.34e-05	0.000341	CcSEcCtD
Naratriptan—Vomiting—Hydrocortisone—atopic dermatitis	7.34e-05	0.00034	CcSEcCtD
Naratriptan—HTR1A—GPCR ligand binding—CXCR3—atopic dermatitis	7.31e-05	0.00227	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL27—atopic dermatitis	7.28e-05	0.00226	CbGpPWpGaD
Naratriptan—Rash—Hydrocortisone—atopic dermatitis	7.28e-05	0.000338	CcSEcCtD
Naratriptan—Dermatitis—Hydrocortisone—atopic dermatitis	7.27e-05	0.000337	CcSEcCtD
Naratriptan—Headache—Hydrocortisone—atopic dermatitis	7.23e-05	0.000335	CcSEcCtD
Naratriptan—HTR1F—Signaling Pathways—KIF3A—atopic dermatitis	7.21e-05	0.00224	CbGpPWpGaD
Naratriptan—Dizziness—Triamcinolone—atopic dermatitis	7.19e-05	0.000333	CcSEcCtD
Naratriptan—Dizziness—Methylprednisolone—atopic dermatitis	7.17e-05	0.000333	CcSEcCtD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	7.16e-05	0.00222	CbGpPWpGaD
Naratriptan—Feeling abnormal—Prednisone—atopic dermatitis	7.08e-05	0.000328	CcSEcCtD
Naratriptan—Asthenia—Betamethasone—atopic dermatitis	7.08e-05	0.000328	CcSEcCtD
Naratriptan—Asthenia—Dexamethasone—atopic dermatitis	7.08e-05	0.000328	CcSEcCtD
Naratriptan—HTR1D—Signaling by GPCR—CCL11—atopic dermatitis	7.06e-05	0.00219	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	7.02e-05	0.00218	CbGpPWpGaD
Naratriptan—Nausea—Prednisolone—atopic dermatitis	7.02e-05	0.000326	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—CXCL10—atopic dermatitis	7e-05	0.00217	CbGpPWpGaD
Naratriptan—Pruritus—Dexamethasone—atopic dermatitis	6.98e-05	0.000324	CcSEcCtD
Naratriptan—Pruritus—Betamethasone—atopic dermatitis	6.98e-05	0.000324	CcSEcCtD
Naratriptan—HTR1D—Signaling Pathways—FCER2—atopic dermatitis	6.96e-05	0.00216	CbGpPWpGaD
Naratriptan—Vomiting—Triamcinolone—atopic dermatitis	6.91e-05	0.00032	CcSEcCtD
Naratriptan—HTR1B—Signaling by GPCR—CCL11—atopic dermatitis	6.91e-05	0.00214	CbGpPWpGaD
Naratriptan—Vomiting—Methylprednisolone—atopic dermatitis	6.9e-05	0.00032	CcSEcCtD
Naratriptan—Nausea—Hydrocortisone—atopic dermatitis	6.86e-05	0.000318	CcSEcCtD
Naratriptan—Rash—Triamcinolone—atopic dermatitis	6.85e-05	0.000318	CcSEcCtD
Naratriptan—Dermatitis—Triamcinolone—atopic dermatitis	6.85e-05	0.000318	CcSEcCtD
Naratriptan—Rash—Methylprednisolone—atopic dermatitis	6.84e-05	0.000317	CcSEcCtD
Naratriptan—Dermatitis—Methylprednisolone—atopic dermatitis	6.83e-05	0.000317	CcSEcCtD
Naratriptan—Urticaria—Prednisone—atopic dermatitis	6.82e-05	0.000316	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—CCL5—atopic dermatitis	6.82e-05	0.00212	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FCER2—atopic dermatitis	6.81e-05	0.00211	CbGpPWpGaD
Naratriptan—Headache—Triamcinolone—atopic dermatitis	6.81e-05	0.000316	CcSEcCtD
Naratriptan—Headache—Methylprednisolone—atopic dermatitis	6.79e-05	0.000315	CcSEcCtD
Naratriptan—Body temperature increased—Prednisone—atopic dermatitis	6.79e-05	0.000315	CcSEcCtD
Naratriptan—Diarrhoea—Betamethasone—atopic dermatitis	6.75e-05	0.000313	CcSEcCtD
Naratriptan—Diarrhoea—Dexamethasone—atopic dermatitis	6.75e-05	0.000313	CcSEcCtD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	6.68e-05	0.00207	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CCL5—atopic dermatitis	6.67e-05	0.00207	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL17—atopic dermatitis	6.53e-05	0.00203	CbGpPWpGaD
Naratriptan—Dizziness—Dexamethasone—atopic dermatitis	6.52e-05	0.000302	CcSEcCtD
Naratriptan—Dizziness—Betamethasone—atopic dermatitis	6.52e-05	0.000302	CcSEcCtD
Naratriptan—HTR1F—Signaling Pathways—CCL11—atopic dermatitis	6.52e-05	0.00202	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CMA1—atopic dermatitis	6.52e-05	0.00202	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL22—atopic dermatitis	6.47e-05	0.00201	CbGpPWpGaD
Naratriptan—Nausea—Triamcinolone—atopic dermatitis	6.46e-05	0.000299	CcSEcCtD
Naratriptan—Nausea—Methylprednisolone—atopic dermatitis	6.44e-05	0.000299	CcSEcCtD
Naratriptan—HTR1F—Signaling by GPCR—CXCL10—atopic dermatitis	6.35e-05	0.00197	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	6.35e-05	0.00197	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CCR3—atopic dermatitis	6.33e-05	0.00197	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL22—atopic dermatitis	6.33e-05	0.00197	CbGpPWpGaD
Naratriptan—Hypersensitivity—Prednisone—atopic dermatitis	6.33e-05	0.000293	CcSEcCtD
Naratriptan—Vomiting—Dexamethasone—atopic dermatitis	6.27e-05	0.000291	CcSEcCtD
Naratriptan—Vomiting—Betamethasone—atopic dermatitis	6.27e-05	0.000291	CcSEcCtD
Naratriptan—Rash—Dexamethasone—atopic dermatitis	6.22e-05	0.000288	CcSEcCtD
Naratriptan—Rash—Betamethasone—atopic dermatitis	6.22e-05	0.000288	CcSEcCtD
Naratriptan—Dermatitis—Dexamethasone—atopic dermatitis	6.21e-05	0.000288	CcSEcCtD
Naratriptan—Dermatitis—Betamethasone—atopic dermatitis	6.21e-05	0.000288	CcSEcCtD
Naratriptan—HTR1B—GPCR downstream signaling—CCR3—atopic dermatitis	6.2e-05	0.00193	CbGpPWpGaD
Naratriptan—Headache—Betamethasone—atopic dermatitis	6.18e-05	0.000286	CcSEcCtD
Naratriptan—Headache—Dexamethasone—atopic dermatitis	6.18e-05	0.000286	CcSEcCtD
Naratriptan—Asthenia—Prednisone—atopic dermatitis	6.16e-05	0.000286	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—CCR5—atopic dermatitis	6.14e-05	0.00191	CbGpPWpGaD
Naratriptan—HTR1D—G alpha (i) signalling events—CXCL8—atopic dermatitis	6.13e-05	0.0019	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—STAT6—atopic dermatitis	6.13e-05	0.0019	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	6.09e-05	0.00189	CbGpPWpGaD
Naratriptan—Pruritus—Prednisone—atopic dermatitis	6.08e-05	0.000282	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—CCL5—atopic dermatitis	6.02e-05	0.00187	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.02e-05	0.00187	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CCR5—atopic dermatitis	6.01e-05	0.00187	CbGpPWpGaD
Naratriptan—HTR1B—G alpha (i) signalling events—CXCL8—atopic dermatitis	6e-05	0.00186	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CXCL10—atopic dermatitis	5.91e-05	0.00183	CbGpPWpGaD
Naratriptan—Diarrhoea—Prednisone—atopic dermatitis	5.88e-05	0.000273	CcSEcCtD
Naratriptan—Nausea—Dexamethasone—atopic dermatitis	5.86e-05	0.000272	CcSEcCtD
Naratriptan—Nausea—Betamethasone—atopic dermatitis	5.86e-05	0.000272	CcSEcCtD
Naratriptan—HTR1F—GPCR ligand binding—CXCL8—atopic dermatitis	5.81e-05	0.0018	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GLB1—atopic dermatitis	5.77e-05	0.00179	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL27—atopic dermatitis	5.77e-05	0.00179	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCR3—atopic dermatitis	5.75e-05	0.00179	CbGpPWpGaD
Naratriptan—Dizziness—Prednisone—atopic dermatitis	5.68e-05	0.000263	CcSEcCtD
Naratriptan—HTR1D—GPCR downstream signaling—NPS—atopic dermatitis	5.65e-05	0.00175	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—TAC1—atopic dermatitis	5.65e-05	0.00175	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL27—atopic dermatitis	5.65e-05	0.00175	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCR3—atopic dermatitis	5.63e-05	0.00175	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CXCR3—atopic dermatitis	5.54e-05	0.00172	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ADSL—atopic dermatitis	5.53e-05	0.00172	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—NPS—atopic dermatitis	5.53e-05	0.00172	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—TAC1—atopic dermatitis	5.53e-05	0.00172	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CCL5—atopic dermatitis	5.47e-05	0.0017	CbGpPWpGaD
Naratriptan—Vomiting—Prednisone—atopic dermatitis	5.46e-05	0.000253	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—CCR5—atopic dermatitis	5.43e-05	0.00168	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CXCR3—atopic dermatitis	5.42e-05	0.00168	CbGpPWpGaD
Naratriptan—Rash—Prednisone—atopic dermatitis	5.42e-05	0.000251	CcSEcCtD
Naratriptan—Dermatitis—Prednisone—atopic dermatitis	5.41e-05	0.000251	CcSEcCtD
Naratriptan—Headache—Prednisone—atopic dermatitis	5.38e-05	0.00025	CcSEcCtD
Naratriptan—HTR1F—Signaling Pathways—CCR3—atopic dermatitis	5.31e-05	0.00165	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL11—atopic dermatitis	5.26e-05	0.00163	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—IL5—atopic dermatitis	5.25e-05	0.00163	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TNF—atopic dermatitis	5.2e-05	0.00161	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FCER2—atopic dermatitis	5.19e-05	0.00161	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL17—atopic dermatitis	5.17e-05	0.00161	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—IL5—atopic dermatitis	5.14e-05	0.0016	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—TAC1—atopic dermatitis	5.13e-05	0.00159	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—NPS—atopic dermatitis	5.13e-05	0.00159	CbGpPWpGaD
Naratriptan—Nausea—Prednisone—atopic dermatitis	5.1e-05	0.000237	CcSEcCtD
Naratriptan—HTR1A—GPCR ligand binding—CCL5—atopic dermatitis	5.08e-05	0.00158	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL17—atopic dermatitis	5.06e-05	0.00157	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCR3—atopic dermatitis	5.03e-05	0.00156	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—TAC1—atopic dermatitis	5.02e-05	0.00156	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—NPS—atopic dermatitis	5.02e-05	0.00156	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CCR5—atopic dermatitis	4.93e-05	0.00153	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CXCR3—atopic dermatitis	4.92e-05	0.00153	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.88e-05	0.00151	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL22—atopic dermatitis	4.82e-05	0.0015	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.77e-05	0.00148	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL5—atopic dermatitis	4.77e-05	0.00148	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TAC1—atopic dermatitis	4.74e-05	0.00147	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NPS—atopic dermatitis	4.74e-05	0.00147	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCR3—atopic dermatitis	4.72e-05	0.00147	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL5—atopic dermatitis	4.67e-05	0.00145	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCR3—atopic dermatitis	4.64e-05	0.00144	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KIF3A—atopic dermatitis	4.61e-05	0.00143	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CCR5—atopic dermatitis	4.58e-05	0.00142	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—CXCL8—atopic dermatitis	4.57e-05	0.00142	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KIF3A—atopic dermatitis	4.51e-05	0.0014	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CXCL10—atopic dermatitis	4.48e-05	0.00139	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	4.42e-05	0.00137	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL5—atopic dermatitis	4.4e-05	0.00137	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CXCL10—atopic dermatitis	4.38e-05	0.00136	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL27—atopic dermatitis	4.3e-05	0.00133	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCR3—atopic dermatitis	4.29e-05	0.00133	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—NPS—atopic dermatitis	4.21e-05	0.00131	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—TAC1—atopic dermatitis	4.21e-05	0.00131	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL6—atopic dermatitis	4.2e-05	0.0013	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL11—atopic dermatitis	4.17e-05	0.00129	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CMA1—atopic dermatitis	4.17e-05	0.00129	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	4.13e-05	0.00128	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL11—atopic dermatitis	4.08e-05	0.00127	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CMA1—atopic dermatitis	4.08e-05	0.00127	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCL10—atopic dermatitis	4.06e-05	0.00126	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CXCL10—atopic dermatitis	3.98e-05	0.00124	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—STAT6—atopic dermatitis	3.92e-05	0.00122	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IL5—atopic dermatitis	3.91e-05	0.00122	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL17—atopic dermatitis	3.86e-05	0.0012	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CCL5—atopic dermatitis	3.85e-05	0.0012	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—STAT6—atopic dermatitis	3.84e-05	0.00119	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—NPS—atopic dermatitis	3.82e-05	0.00119	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—TAC1—atopic dermatitis	3.82e-05	0.00119	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CCL5—atopic dermatitis	3.77e-05	0.00117	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCL10—atopic dermatitis	3.75e-05	0.00117	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCR3—atopic dermatitis	3.75e-05	0.00116	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—CXCL8—atopic dermatitis	3.71e-05	0.00115	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.64e-05	0.00113	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CXCL8—atopic dermatitis	3.64e-05	0.00113	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.57e-05	0.00111	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL5—atopic dermatitis	3.56e-05	0.0011	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCL5—atopic dermatitis	3.5e-05	0.00109	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CCR5—atopic dermatitis	3.47e-05	0.00108	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KIF3A—atopic dermatitis	3.44e-05	0.00107	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL5—atopic dermatitis	3.43e-05	0.00106	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CCR5—atopic dermatitis	3.4e-05	0.00105	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCR3—atopic dermatitis	3.4e-05	0.00105	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	3.34e-05	0.00104	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCR3—atopic dermatitis	3.33e-05	0.00103	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CXCL8—atopic dermatitis	3.28e-05	0.00102	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL5—atopic dermatitis	3.23e-05	0.001	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCR5—atopic dermatitis	3.15e-05	0.000978	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—IL2—atopic dermatitis	3.14e-05	0.000973	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CMA1—atopic dermatitis	3.11e-05	0.000965	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL11—atopic dermatitis	3.11e-05	0.000965	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCR5—atopic dermatitis	3.09e-05	0.000958	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCL10—atopic dermatitis	3.03e-05	0.000941	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TAC1—atopic dermatitis	3.03e-05	0.00094	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NPS—atopic dermatitis	3.03e-05	0.00094	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NGF—atopic dermatitis	2.99e-05	0.000929	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CXCL8—atopic dermatitis	2.98e-05	0.000925	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCR3—atopic dermatitis	2.97e-05	0.000922	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TAC1—atopic dermatitis	2.97e-05	0.000921	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NPS—atopic dermatitis	2.97e-05	0.000921	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STAT6—atopic dermatitis	2.92e-05	0.000907	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCR5—atopic dermatitis	2.91e-05	0.000904	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCR3—atopic dermatitis	2.91e-05	0.000903	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCL5—atopic dermatitis	2.87e-05	0.000892	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL2—atopic dermatitis	2.85e-05	0.000884	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL5—atopic dermatitis	2.82e-05	0.000874	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CXCL8—atopic dermatitis	2.77e-05	0.00086	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL5—atopic dermatitis	2.76e-05	0.000856	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL5—atopic dermatitis	2.61e-05	0.00081	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCR5—atopic dermatitis	2.59e-05	0.000804	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCR3—atopic dermatitis	2.53e-05	0.000787	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NFKBIA—atopic dermatitis	2.47e-05	0.000766	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCL10—atopic dermatitis	2.4e-05	0.000745	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	2.35e-05	0.00073	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL10—atopic dermatitis	2.35e-05	0.00073	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NPS—atopic dermatitis	2.26e-05	0.000701	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	2.26e-05	0.000701	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	2.22e-05	0.000688	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL5—atopic dermatitis	2.1e-05	0.000652	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	2.1e-05	0.000651	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	2.07e-05	0.000642	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	2.05e-05	0.000638	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	2.02e-05	0.000628	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	2.01e-05	0.000622	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	1.96e-05	0.00061	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NGF—atopic dermatitis	1.91e-05	0.000594	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	1.91e-05	0.000591	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NGF—atopic dermatitis	1.87e-05	0.000582	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARA—atopic dermatitis	1.87e-05	0.000581	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	1.87e-05	0.000579	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	1.86e-05	0.000578	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	1.82e-05	0.000566	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	1.82e-05	0.000565	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	1.79e-05	0.000556	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	1.78e-05	0.000553	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCL8—atopic dermatitis	1.76e-05	0.000546	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL2—atopic dermatitis	1.68e-05	0.000522	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—atopic dermatitis	1.67e-05	0.00052	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	1.58e-05	0.00049	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.57e-05	0.000486	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAPK8—atopic dermatitis	1.55e-05	0.000481	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	1.55e-05	0.00048	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	1.54e-05	0.000479	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	1.5e-05	0.000464	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NGF—atopic dermatitis	1.43e-05	0.000443	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	1.42e-05	0.000441	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	1.39e-05	0.000431	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	1.36e-05	0.000422	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	1.18e-05	0.000365	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	1.13e-05	0.000349	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	1.1e-05	0.000342	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL2—atopic dermatitis	1.08e-05	0.000334	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	1.07e-05	0.000332	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL2—atopic dermatitis	1.05e-05	0.000327	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	1.05e-05	0.000325	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	9.9e-06	0.000307	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—atopic dermatitis	9.89e-06	0.000307	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	9.69e-06	0.000301	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	8.4e-06	0.000261	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL2—atopic dermatitis	8.02e-06	0.000249	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	7.98e-06	0.000248	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	7.39e-06	0.000229	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—atopic dermatitis	6.32e-06	0.000196	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—atopic dermatitis	6.19e-06	0.000192	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—atopic dermatitis	4.72e-06	0.000146	CbGpPWpGaD
